Objective
to repeat the 3-year clinical outcomes of intravascular ultrasound guidance (IVUS) versus angiographic guidance (Angio) during DES implantation
Study
prospective, investigator-initiated multicentre randomised trial
Population
all-comers undergoing DES-implantation
Endpoints
TVF as cardiac death, target vessel MI and clinically driven target vessel revascularisation at 3 years


Conclusion
IVUS-guided DES implantation was associated with significantly less 3-year MACE as compared to angio guided implantation
Gao et al. J Am Coll Cardiol Intv. 2021;14:247-57